Physician profile
Gary Peng
NPI 1588152151
$12,295.60
in general payments reported to CMS, 2019-2025
6 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $110 · 2024: $216 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,714 · Food and Beverage: $3,094 · Travel and Lodging: $2,084 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,714.14 |
| Food and Beverage | $3,093.58 |
| Travel and Lodging | $2,084.46 |
| Education | $293.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,217.41 | 2025 | Assurity, Tacticath, Amplatzer Amulet |
| Boston Scientific Corporation | $4,119.71 | 2025 | General - Therapies, Emblem Mri S-Icd, Versacross Rf Wire |
| Medtronic, INC. | $3,005.99 | 2025 | |
| Biosense Webster, INC. | $750.63 | 2024-2025 | Carto 3 |
| Astellas Pharma US INC | $109.99 | 2022 | |
| Heartflow, INC. | $91.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Peng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.